Neutralizing antibodies for the treatment of COVID-19,Nature Biomedical Engineering

当前位置： X-MOL 学术 › Nat. Biomed. Eng. › 论文详情

Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)

Neutralizing antibodies for the treatment of COVID-19
Nature Biomedical Engineering ( IF 26.8 ) Pub Date : 2020-12-08 , DOI: 10.1038/s41551-020-00660-2
Shibo Jiang _{1,

2} , Xiujuan Zhang ₁ , Yang Yang _{3,

4} , Peter J Hotez ₅ , Lanying Du ₁

Affiliation

More clinical trial data are needed to determine whether sera from COVID-19-convalescent patients and neutralizing monoclonal antibodies specific to SARS-CoV-2 antigens can prevent COVID-19 or reduce the severity of the disease in high-risk populations.

中文翻译：